RESUMEN
The United States Food and Drug Administration (FDA) ensures that patients in the United States have access to safe and effective medical devices. The division of neurological and physical medicine devices reviews medical technologies that interface with the nervous system, including many neuromodulation devices. This article focuses on neuromodulation devices and addresses how to navigate the FDA's regulatory landscape to successfully bring devices to patients.
Asunto(s)
Aprobación de Recursos/legislación & jurisprudencia , Aprobación de Recursos/normas , Neuroestimuladores Implantables/normas , Estimulación Eléctrica Transcutánea del Nervio/normas , Humanos , Estimulación Eléctrica Transcutánea del Nervio/instrumentación , Estados UnidosRESUMEN
The United States Food and Drug Administration (FDA) ensures that patients in the U.S. have access to safe and effective medical devices. The Division of Neurological and Physical Medicine Devices reviews medical technologies that interface with the nervous system. This article addresses how to navigate the FDA's regulatory landscape to successfully bring medical devices to patients.